Alex Therapeutics
Founded 2018 · 31 employees on LinkedIn · 5 known investors
Find your way into Alex Therapeutics
Alex Therapeutics builds clinically validated digital therapeutics and therapy companion apps that combine CBT-based interventions, consumer product design, and AI/ML to support patients managing complex conditions such as rare diseases and cancer. It works as a health technology partner for life sciences and pharmaceutical companies developing regulated digital health products.
Founders & leadership
Alex Therapeutics was founded in 2018 by John Drakenberg and Oliver Fleetwood.
Investors · 5
How we know: Hadean Ventures's portfolio page · funding news · prnewswire.com · Not right? Tell us
How we know: Innovestor Ventures's portfolio page · Not right? Tell us
How we know: Scale Capital's portfolio page · funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 2
In the news
Frequently asked questions
- What does Alex Therapeutics do?
- Alex Therapeutics builds clinically validated digital therapeutics and therapy companion apps that combine CBT-based interventions, consumer product design, and AI/ML to support patients managing complex conditions such as rare diseases and cancer. It works as a health technology partner for life sciences and pharmaceutical companies developing regulated digital health products.
- Who founded Alex Therapeutics?
- Alex Therapeutics was founded by John Drakenberg, Oliver Fleetwood in 2018.
- Who are Alex Therapeutics's investors?
- Alex Therapeutics's investors include Hadean Ventures, Innovestor Ventures, Scale Capital.



